| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |